We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-7.16%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.97B
AUM Growth
-$499M
Cap. Flow
-$86.7M
Cap. Flow %
-2.18%
Top 10 Hldgs %
7.73%
Holding
1,278
New
86
Increased
451
Reduced
486
Closed
106

Top Buys

Rank Stock Value
1
SDRL icon
Seadrill
SDRL
+$12.9M
2
KMT icon
Kennametal
KMT
+$12.6M
3
VVX icon
V2X
VVX
+$11M
4
BTU icon
Peabody Energy
BTU
+$10.8M
5
WERN icon
Werner Enterprises
WERN
+$10.4M

Sector Composition

Rank Sector Weight
1 Financials 29.14%
2 Industrials 12.03%
3 Consumer Discretionary 11.43%
4 Technology 10.07%
5 Energy 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMUX icon
1001
Immunic
IMUX
$195M
$125K ﹤0.01%
11,500
-10,000
-47% -$108K
RAPT
1002
DELISTED
RAPT Therapeutics
RAPT
$122K ﹤0.01%
12,500
-3,125
-20% -$30.7K
UG icon
1003
United-Guardian
UG
$33.5M
$121K ﹤0.01%
13,466
SMRT icon
1004
SmartRent
SMRT
$272M
$121K ﹤0.01%
+100,000
New +$140K
ATNM icon
1005
Actinium Pharmaceuticals
ATNM
$25M
$121K ﹤0.01%
75,000
-700
-0.9% -$889
NTWK icon
1006
NetSol Technologies
NTWK
$50.6M
$118K ﹤0.01%
48,892
+2,152
+5% +$5.45K
FLNT
1007
Fluent
FLNT
$120M
$117K ﹤0.01%
53,868
+101
+0.2% +$267
PPSI
1008
Pioneer Power Solutions
PPSI
$34.3M
$117K ﹤0.01%
39,200
ACCS
1009
ACCESS Newswire
ACCS
$26.3M
$117K ﹤0.01%
13,268
-4,000
-23% -$37.8K
CHRS icon
1010
Coherus Oncology
CHRS
$196M
$115K ﹤0.01%
143,000
-60,000
-30% -$69.1K
KRMD icon
1011
KORU Medical Systems
KRMD
$164M
$115K ﹤0.01%
+45,305
New +$168K
IRD
1012
Opus Genetics
IRD
$302M
$114K ﹤0.01%
116,501
QVCGA
1013
DELISTED
QVC Group Inc Series A
QVCGA
$114K ﹤0.01%
11,346
+697
+7% +$11.1K
VTYX
1014
DELISTED
Ventyx Biosciences
VTYX
$113K ﹤0.01%
98,600
-106,900
-52% -$184K
BDTX icon
1015
Black Diamond Therapeutics
BDTX
$112M
$113K ﹤0.01%
73,100
-71,500
-49% -$150K
NEOV icon
1016
NeoVolta
NEOV
$156M
$113K ﹤0.01%
+52,200
New +$175K
ELDN icon
1017
Eledon Pharmaceuticals
ELDN
$285M
$113K ﹤0.01%
33,400
RRGB icon
1018
Red Robin
RRGB
$152M
$113K ﹤0.01%
31,700
-33,800
-52% -$173K
SPRO icon
1019
Spero Therapeutics
SPRO
$73M
$111K ﹤0.01%
154,800
-30,000
-16% -$25.3K
UONEK icon
1020
Urban One Class D
UONEK
$23.8M
$111K ﹤0.01%
15,425
+16
+0.1% +$127
KORE
1021
DELISTED
KORE Group Holdings
KORE
$111K ﹤0.01%
44,740
YMAB
1022
DELISTED
Y-mAbs Therapeutics
YMAB
$110K ﹤0.01%
24,900
-25,000
-50% -$145K
RVP icon
1023
Retractable Technologies
RVP
$20.1M
$109K ﹤0.01%
155,630
+10,800
+7% +$8.38K
ENTA icon
1024
Enanta Pharmaceuticals
ENTA
$400M
$109K ﹤0.01%
19,700
-26,500
-57% -$164K
IDN icon
1025
Intellicheck
IDN
$79.6M
$109K ﹤0.01%
35,847
-25,453
-42% -$67.1K

Similar funds

Bridgeway Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Bridgeway Capital Management held 1,278 positions worth $3.97B, down 11% from $4.47B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Bridgeway Capital Management's Q1 2025 filing shows 86 new, 451 increased, 486 reduced and 106 closed positions. Its largest new stake was Seadrill: 415,580 shares worth $10.4M. The largest sale was Patrick Industries, an estimated $19.9M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Bridgeway Capital Management's largest Q1 2025 buy was Seadrill: 415,580 shares worth $10.4M.
  • Bridgeway Capital Management added most to Hamilton Insurance Group in Q1 2025, an estimated $9.08M increase.
  • Bridgeway Capital Management's biggest Q1 2025 reduction was EchoStar, cutting an estimated $13.9M.
  • Bridgeway Capital Management fully exited Patrick Industries in Q1 2025, selling an estimated $19.9M.
  • Bridgeway Capital Management's ten largest holdings make up 7.7% of its $3.97B portfolio in Q1 2025.
  • Bridgeway Capital Management opened 86 new positions and closed 106 in Q1 2025.
  • Bridgeway Capital Management's portfolio value fell 11% quarter-over-quarter to $3.97B.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.